“Health Conditions In An Adult Population In Sierra Leone: Data Reported From The Sierra Leone Trial To Introduce A Vaccine Against Ebola (Strive).”. J Infect Dis 217 (suppl_1). J Infect Dis: S75-S80. doi:10.1093/infdis/jix603.
. 2018. “Late Effects After Umbilical Cord Blood Transplantation In Very Young Children After Busulfan-Based, Myeloablative Conditioning.”. Biol Blood Marrow Transplant 22 (9). Biol Blood Marrow Transplant: 1627-1635. doi:10.1016/j.bbmt.2016.05.024.
. 2016. “Monitoring Serious Adverse Events In The Sierra Leone Trial To Introduce A Vaccine Against Ebola.”. J Infect Dis 217 (suppl_1). J Infect Dis: S24-S32. doi:10.1093/infdis/jiy042.
. 2018. “A Phase I Trial To Evaluate The Safety And Immunogenicity Of Wrss2 And Wrss3; Two Live Oral Candidate Vaccines Against Shigella Sonnei.”. Vaccine 36 (32 Pt B). Vaccine: 4880-4889. doi:10.1016/j.vaccine.2018.06.063.
. 2018. “Randomized Comparison Of Allogeneic Versus Autologous Mesenchymal Stem Cells For Nonischemic Dilated Cardiomyopathy: Poseidon-Dcm Trial.”. J Am Coll Cardiol 69 (5). J Am Coll Cardiol: 526-537. doi:10.1016/j.jacc.2016.11.009.
. 2017. “Safety And Immunogenicity Of A Parenterally Administered, Structure-Based Rationally Modified Recombinant Staphylococcal Enterotoxin B Protein Vaccine, Stebvax.”. Clin Vaccine Immunol 23 (12). Clin Vaccine Immunol: 918-925. doi:10.1128/CVI.00399-16.
. 2016. “Safety And Immunogenicity Of Sequential Rotavirus Vaccine Schedules.”. Pediatrics 137 (2). Pediatrics: e20152603. doi:10.1542/peds.2015-2603.
. 2016.